Google: A Quiet Giant Poised for a New Leg Higher

I’ve held a long term position in Alphabet (GOOGL) for the better part of 5 years now. While Meta grabbed headlines with efficiency, Nvidia became the face of AI infrastructure, and Microsoft rode the enterprise AI wave, Google looked… steady. Almost too steady.

But lately, the narrative has shifted. A surprising investor just quietly validated Google’s long-term opportunity:

The Oracle, who famously avoided tech for decades, has now taken a meaningful stake in Alphabet. And when you unpack why, the case for Google in 2026 and beyond becomes much more compelling—especially once you layer in a major emerging trend: AI in pharmaceuticals, where Google is sitting on one of the most powerful assets in the industry through Isomorphic Labs.

Let’s break it down.